ArticleDiabetes2012
Mesenchymal stem cells for the treatment of diabetes.
Abstract readComment
In one paragraph
Article in Diabetes, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 3 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Efficacy of mesenchymal stem cell therapy on glucose levels in type 2 diabetes mellitus: A systematic review and meta-analysis.Journal of diabetes investigation · 2021Pooled it
- Pooled it
- Pooled it
- A Pilot Study of Mesenchymal Stem Cell Therapy for Acute Liver Allograft Rejection.Stem cells translational medicine · 2017Trial
- Mesenchymal stem cell-based therapy for type 1 & 2 diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trials.Diabetology & metabolic syndrome · 2025Article
- Stem Cells Reprogramming in Diabetes Mellitus and Diabetic Complications: Recent Advances.Current diabetes reviews · 2025Review
- Article
- A Supportive Role of Mesenchymal Stem Cells on Insulin-Producing Langerhans Islets with a Specific Emphasis on The Secretome.Biomedicines · 2023Review
- The Usefulness of Mesenchymal Stem Cells beyond the Musculoskeletal System in Horses.Animals : an open access journal from MDPI · 2021Review
- In Vivo Study for Clinical Application of Dental Stem Cell Therapy Incorporated with Dental Titanium Implants.Materials (Basel, Switzerland) · 2021Article
- Extracellular Microvesicles (MV's) Isolated from 5-Azacytidine-and-Resveratrol-Treated Cells Improve Viability and Ameliorate Endoplasmic Reticulum Stress in Metabolic Syndrome Derived Mesenchymal Stem Cells.Stem cell reviews and reports · 2020Article
- Immunomodulatory Approaches in Diabetes-Induced Cardiorenal Syndromes.Frontiers in cardiovascular medicine · 2020Review
- Therapeutic Potential of Wharton's Jelly Mesenchymal Stem Cells for Diabetes: Achievements and Challenges.Frontiers in cell and developmental biology · 2020Review
- Human adipose tissue mesenchymal stem cells as a novel treatment modality for correcting obesity induced metabolic dysregulation.International journal of obesity (2005) · 2019Article
- Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice.Stem cell research & therapy · 2019Article
- 5-Azacytydine and resveratrol reverse senescence and ageing of adipose stem cells via modulation of mitochondrial dynamics and autophagy.Journal of cellular and molecular medicine · 2019Article
- Combination of resveratrol and 5-azacytydine improves osteogenesis of metabolic syndrome mesenchymal stem cells.Journal of cellular and molecular medicine · 2018Article
- Ferumoxytol-based Dual-modality Imaging Probe for Detection of Stem Cell Transplant Rejection.Nanotheranostics · 2018Article
- Neural Stem Cells and Its Derivatives as a New Material for Melanin Inhibition.International journal of molecular sciences · 2017Review
- Mesenchymal stem cells: a future experimental exploration for recession of diabetic nephropathy.Renal failure · 2017Article
Corrections and comments
- Comment on
Authors and funding
1 author.
Antonello PileggiCell Transplant Center, Diabetes Research Institute, DeWitt Daughtry Family Department of Surgery, Department of Microbiology and Immunology, and Department of Biomedical Engineering, University of Miami, Miami, Florida, USA. apileggi@med.miami.edu
Funding
Virginia Mason/UCHSC Autoimmune Prevention CenterU19AI050864 · NIAID · UNIVERSITY OF COLORADO DENVER · PI EISENBARTH, GEORGE S · 2001 to 2011
$29.2MStrategies to Improve Long Term Islet Graft SurvivalU01DK070460 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI RICORDI, CAMILLO · 2004 to 2012
$11.6MISLET CELL RESOURCE FOR DIABETES RESEARCH AND TREATMENTU42RR016603 · NCRR · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI RICORDI, CAMILLO · 2001 to 2009
$7.8MPATHWAYS TO TOLERANCE IN HUMAN ISLET TRANSPLANTATIONR01DK056953 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI RICORDI, CAMILLO · 2000 to 2004
$5.1MMulti-Disciplinary Approaches to Driving Therapeutic Human Beta Cell ReplicationU01DK089538 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STEWART, ANDREW F. · 2010 to 2014
$3.6MInsulin Producing Cells from Amniotic Stem Cells for Diabetes TherapyR01EB008009 · NIBIB · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ATALA, ANTHONY · 2007 to 2009
$3.3MPANCREATIC TRANSPLANTATION AND DIABETIC MELLITUSR01DK025802 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI INVERARDI, LUCA · 1986 to 2005
$2.5MFunctionalized, Nanoscale Coatings for Islet EncapsulationDP2DK083096 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI STABLER, CHERIE L · 2008 to 2011
$2.5MNOVEL STRATEGIES TO IMPROVE VIABILITY OF ISLETSR01DK059993 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PASTORI, RICARDO L · 2002 to 2009
$1.6MNovel Chimeric Molecule to Improve Islet transplantationR21DK076098 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI PASTORI, RICARDO L · 2006 to 2007
$375kNCRR NIH HHS 5U42RR016603-08S1NCRR NIH HHS U42 RR016603NIAID NIH HHS 5U19AI050864-10NIAID NIH HHS U19 AI050864NIBIB NIH HHS 1R01EB008009-02NIBIB NIH HHS R01 EB008009NIDDK NIH HHS 1DP2DK083096-01NIDDK NIH HHS 1 R21 DK076098-01NIDDK NIH HHS 1 U01 DK70460-02NIDDK NIH HHS 5R01DK059993-06NIDDK NIH HHS 5R01DK25802-24NIDDK NIH HHS 5R01DK56953-05NIDDK NIH HHS DP2 DK083096NIDDK NIH HHS R01 DK025802NIDDK NIH HHS R01 DK056953NIDDK NIH HHS R01 DK059993NIDDK NIH HHS R21 DK076098NIDDK NIH HHS U01 DK070460NIDDK NIH HHS U01 DK089538NIDDK NIH HHS U01DK089538
Abstract
PubMed holds no abstract for this paper.
Indexed as
AnimalsDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2HyperglycemiaInsulin ResistanceMesenchymal Stem CellsMesenchymal Stem Cell Transplantation
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.